T1	Procedure 28 42	histologically
T2	Value 43 52	confirmed
R1	Has_value Arg1:T1 Arg2:T2	
T3	Condition 57 60	NHL
T4	Condition 64 66	HL
T5	Scope 57 66	NHL or HL
T8	Qualifier 53 56	R/R
R2	Has_qualifier Arg1:T5 Arg2:T8	
T9	Measurement 79 91	WHO criteria
R3	AND Arg1:T8 Arg2:T9	
R4	Subsumes Arg1:T2 Arg2:T9	
T10	Scope 53 66	R/R NHL or HL
T11	Procedure 108 142	chronic lymphocytic leukemia (CLL)
T12	Procedure 147 179	small lymphocytic lymphoma (SLL)
T13	Grammar_Error 143 146	and
*	OR T11 T12
T14	Condition 221 224	NHL
T15	Condition 236 274	diffuse large B cell lymphomas (DLBCL)
T16	Multiplier 294 304	at least 2
T17	Negation 225 235	other than
R6	Has_negation Arg1:T15 Arg2:T17	
T18	Scope 221 274	NHL other than diffuse large B cell lymphomas (DLBCL)
A1	Optional T18
T19	Procedure 311 320	therapies
T20	Temporal 305 310	prior
T21	Context_Error 311 320	therapies
R8	Has_temporal Arg1:T19 Arg2:T20	
R9	Has_multiplier Arg1:T19 Arg2:T16	
R7	AND Arg1:T18 Arg2:T19	
T22	Condition 336 341	DLBCL
T23	Condition 346 348	HL
T24	Grammar_Error 342 345	and
*	OR T22 T23
T25	Procedure 391 407	standard therapy
T26	Undefined_semantics 391 407	standard therapy
T27	Negation 378 380	no
R10	Has_negation Arg1:T25 Arg2:T27	
T28	Scope 336 348	DLBCL and HL
A2	Optional T28
R11	AND Arg1:T28 Arg2:T25	
T29	Measurement 439 453	histologically
T30	Qualifier 464 467	R/R
*	OR T4 T3
R5	AND Arg1:T5 Arg2:T1	
T6	Condition 468 471	NHL
R12	Has_qualifier Arg1:T6 Arg2:T30	
T7	Measurement 487 499	WHO criteria
T31	Value 454 463	confirmed
R13	Has_value Arg1:T29 Arg2:T31	
R14	Subsumes Arg1:T31 Arg2:T7	
T32	Condition 516 519	NHL
T33	Condition 531 569	diffuse large B cell lymphomas (DLBCL)
T34	Negation 520 530	other than
R15	Has_negation Arg1:T33 Arg2:T34	
R16	AND Arg1:T32 Arg2:T33	
T35	Multiplier 589 599	at least 2
T36	Temporal 600 605	prior
T37	Procedure 606 615	therapies
T38	Undefined_semantics 606 615	therapies
T39	Context_Error 311 320	therapies
T40	Context_Error 606 615	therapies
R17	Has_temporal Arg1:T37 Arg2:T36	
R18	Has_multiplier Arg1:T37 Arg2:T35	
T41	Scope 516 569	NHL other than diffuse large B cell lymphomas (DLBCL)
A3	Optional T41
R19	AND Arg1:T41 Arg2:T37	
T42	Condition 631 636	DLBCL
T43	Procedure 679 695	standard therapy
T44	Undefined_semantics 679 695	standard therapy
T45	Negation 666 668	no
R20	Has_negation Arg1:T43 Arg2:T45	
A4	Optional T42
R21	AND Arg1:T42 Arg2:T43	
T46	Procedure 728 740	chemotherapy
T47	Qualifier 717 727	front line
R22	Has_qualifier Arg1:T46 Arg2:T47	
T48	Not_a_criteria 742 790	No upper limit for the number of prior therapies
T49	Condition 802 809	Disease
T50	Qualifier 792 801	Evaluable
T51	Temporal 810 824	in the Phase I
A5	Optional T51
T52	Temporal 849 864	in the Phase II
A6	Optional T52
T53	Qualifier 830 840	measurable
R23	Has_qualifier Arg1:T51 Arg2:T50	
R25	Has_qualifier Arg1:T52 Arg2:T53	
*	OR T53 T50
R24	Has_qualifier Arg1:T49 Arg2:T53	
T54	Person 866 869	Age
T55	Value 870 880	> 18 years
R26	Has_value Arg1:T54 Arg2:T55	
T56	Measurement 882 905	ECOG performance status
T57	Value 906 909	< 2
R27	Has_value Arg1:T56 Arg2:T57	
T58	Measurement 939 944;956 964	organ function
T59	Measurement 949 964	marrow function
T60	Value 930 938	adequate
T61	Subjective_judgement 930 938	adequate
T62	Undefined_semantics 930 938	adequate
R28	Has_value Arg1:T58 Arg2:T60	
R29	Has_value Arg1:T59 Arg2:T60	
T63	Procedure 975 988	Contraception
T64	Qualifier 966 974	Adequate
T65	Undefined_semantics 966 974	Adequate
T66	Subjective_judgement 966 974	Adequate
R30	Has_qualifier Arg1:T63 Arg2:T64	
T67	Post-eligibility 990 1075	Ability to understand and the willingness to sign a written informed consent document
T68	Non-query-able 990 1075	Ability to understand and the willingness to sign a written informed consent document
